Tag Archives: cell

FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Lumakras (sotorasib) for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell… Read More »

These Sisters With Sickle Cell Had Devastating, and Preventable, Strokes

Kyra, left, and Kami Crawford, of San Antonio, are both living with sickle cell, a common complication of which is stroke. These Sisters With Sickle Cell Had Devastating, and Preventable, Strokes Kyra and Kami never got a simple test that could have protected them. Their story exemplifies the failure to care for people with the… Read More »

Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »

Bristol Myers, hot off Breyanzi nod, plots new cell therapy factory in Massachusetts

Bristol Myers Squibb, freshly armed with an approval for its CAR-T lymphoma therapy Breyanzi, is making a major cell therapy manufacturing play. The company is building out a new 244,000-square-foot cell therapy site, housed at the company’s 89-acre campus in Devens, Massachusetts. The new factory will be kitted out to quickly ramp up clinical and commercial production, augmenting Bristol’s existing… Read More »

Novel adoptive cell transfer method shortens timeline for T-cell manufacture

Adoptively transferred T-cells can prolong survival and sometimes cure patients with advanced solid tumors. While promising, it can take months to generate the necessary T-cells to help these patients. Such slow speed makes this therapy impractical for most patients who need immediate treatment. In the September issue of Cancer Research, Hannah Knochelmann, a student in… Read More »

Small Cell Forum Shows Leveraging Edge and Small Cell Synergies Optimizes Value For Service Providers and Enterprises

New analysis outlines significant market opportunities and details work required to realize the potential of combined small cell/edge solutions London, UK, 10th June 2020 Small Cell Forum (SCF) today published research setting out how edge computing will impact the future of small cell networks, with particular focus on private cellular networks. A survey of service… Read More »